Modern Medicine Feature Articles

ODs’ top 4 gripes about vision care plans
ODs’ top 4 gripes about vision care plansVision care plans (VCP) can be difficult to figure out because each provider tends to have its own set of rules. In an attempt to bring clarity to the VCP landscape, I have put together a five-part series of blogs.
How to use tear osmolarity to help treat dry eye disease
How concerned are you about radiation exposure?Urology Times reached out to four urologists (selected randomly) and asked them each the following question: How concerned are you about radiation exposure?
New topical hemostatic device in pipelineIf cleared, dermatologists might find the technology useful when excising lesions in patients on blood thinners and more.
Failed cell therapy study offers positives, raises new questionsPatients with a history of frequent anti-vascular endothelial growth factor (anti-VEGF) injections for the treatment of age-related macular degeneration (AMD) may not be the best potential candidates for encapsulated cell technology (ECT).
Investigational wet AMD therapies aim for innovative targetsMany investigational drugs under development for the treatment of neovascular age-related macular degeneration (nvAMD) have advanced into the clinical trial stage, including several that are being evaluated in pivotal trials, said Peter K. Kaiser, MD.
Spacer system maintains QoL at 3 years post RTPhase III study results suggest that a hydrogel spacer developed to separate the rectum and prostate during radiotherapy for prostate cancer works to maintain bowel and urinary quality of life and reduces late rectal toxicity by 78% at 3 years post radiotherapy.
Quiz: Pediatric recurrent UTIs, abdomen painA 5-year-old girl is evaluated for recurrent urinary tract infections and lower abdomen pain. A kidney, ureter, and bladder x-ray and computed tomography are obtained.
How to care for stroke patientsOptometrists are able to address the visual needs of stroke survivors, an underserved population.
Role of molecular biomarkers in localized prostate cancer